(Q53363037)

13 May 2018

http://europepmc.org/abstract/MED/26319660

title

Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. (English)

1 reference

13 May 2018

http://europepmc.org/abstract/MED/26319660

main subject

myocardial infarction

1 reference

Jochen Tillmanns

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Daniel Hoffmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yasmin Habbaba

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Daniel Sedding

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Daniela Fraccarollo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Paolo Galuppo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

28 August 2015

1 reference

13 May 2018

http://europepmc.org/abstract/MED/26319660

published in

Journal of Molecular and Cellular Cardiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

194-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

Novel therapeutic approaches to post-infarction remodelling

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Myocardial remodeling after infarction: the role of myofibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Myocardial fibroblast-matrix interactions and potential therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Myofibroblasts and mechano-regulation of connective tissue remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Targeted disruption of mouse fibroblast activation protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Formation of large coronary arteries by cardiac progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

PET imaging of cardiac wound healing using a novel [68Ga]-labeled NGR probe in rat myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Thy-1 expression by cardiac fibroblasts: Lack of association with myofibroblast contractile markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

The origin of fibroblasts and mechanism of cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

The role of TGF-beta signaling in myocardial infarction and cardiac remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Cardiomyocyte-specific transforming growth factor β suppression blocks neutrophil infiltration, augments multiple cytoprotective cascades, and reduces early mortality after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Connective tissue growth factor and cardiac fibrosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Molecular imaging of the cardiac extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.08.016

10.1016/J.YJMCC.2015.08.016

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26319660%20AND%20SRC:MED&resulttype=core&format=json

release_fqcdcd4bbrhytoc5rwhkrwc7au

1 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fqcdcd4bbrhytoc5rwhkrwc7au

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference